Search Results
11 results found for "minnesota"
- When Public Health Becomes Profit over Patients
Evidence from Minnesota’s 340B Reporting Initiative Minnesota’s 340B Covered Entity Report, established revenues were allocated to federal grantee entities Disproportionate gains for large hospital systems: Minnesota
- Prescription Drug Advisory Boards: Who is Impacted and How to get Involved
had, have or are in the process of enacting PDAB legislation: Washington, Oregon, Colorado, Michigan, Minnesota ability to enact binding upper payment limit (UPL) settings: Washington, Oregon, Colorado, Maryland, and Minnesota
- Amid HIV Outbreaks, Covid-19 Fractures Existing Public Health Efforts
And Duluth, outside of Saint Louis, Minnesota, joined neighboring Hennepin and Ramsey Counties with declared
- Opioid Settlements in America
To date, just 15 states (Arizona, Colorado, Connecticut, Delaware, Florida, Idaho, Massachusetts, Minnesota
- Are Federal Spending Cuts Endangering America's Most Vulnerable?
Minnesota's Department of Health has issued layoff notices to 170 workers and rescinded offers to 20
- HIV/HCV Co-Infection Watch Q2: April 2025
the Alohacare Advantage Plus plan; Indiana has added Vosevi coverage with prior authorization; and Minnesota Minnesota no longer covers Zapatier or Vosevi. Minnesota has moved Vosevi from preferred to nonpreferred.
- HIV/HCV Co-Infection Watch Q1: January 2024
Minnesota no longer covers Zapatier or Vosevi. BACK TO TOP 3.
- HIV/HCV Co-Infection Watch Q1: January 2025
Minnesota no longer covers Zapatier or Vosevi.
- HIV/HCV Co-Infection Watch Q2: April 2024
Minnesota no longer covers Zapatier or Vosevi.
- HIV/HCV Co-Infection Watch Q3: July 2024
Minnesota no longer covers Zapatier or Vosevi.
- HIV/HCV Co-Infection Watch Q4: October 2024
Minnesota no longer covers Zapatier or Vosevi.
